Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a major health threat around the world and is characterized by dysbiosis. Primary bile acids are synthesized in the liver and converted into secondary bile acids by gut microbiota. Recent studies support the role of bile acids in modulating dysbiosis and N...

Full description

Saved in:
Bibliographic Details
Main Authors: Caihua Wang, Chunpeng Zhu, Liming Shao, Jun Ye, Yimin Shen, Yuezhong Ren
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/7659509
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560293967822848
author Caihua Wang
Chunpeng Zhu
Liming Shao
Jun Ye
Yimin Shen
Yuezhong Ren
author_facet Caihua Wang
Chunpeng Zhu
Liming Shao
Jun Ye
Yimin Shen
Yuezhong Ren
author_sort Caihua Wang
collection DOAJ
description Nonalcoholic fatty liver disease (NAFLD) is a major health threat around the world and is characterized by dysbiosis. Primary bile acids are synthesized in the liver and converted into secondary bile acids by gut microbiota. Recent studies support the role of bile acids in modulating dysbiosis and NAFLD, while the mechanisms are not well elucidated. Dysbiosis may alter the size and the composition of the bile acid pool, resulting in reduced signaling of bile acid receptors such as farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5). These receptors are essential in lipid and glucose metabolism, and impaired bile acid signaling may cause NAFLD. Bile acids also reciprocally regulate the gut microbiota directly via antibacterial activity and indirectly via FXR. Therefore, bile acid signaling is closely linked to dysbiosis and NAFLD. During the past decade, stimulation of bile acid receptors with their agonists has been extensively explored for the treatment of NAFLD in both animal models and clinical trials. Early evidence has suggested the potential of bile acid receptor agonists in NAFLD management, but their long-term safety and effectiveness need further clarification.
format Article
id doaj-art-09cd77a275204c4d9b41e14133934339
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-09cd77a275204c4d9b41e141339343392025-02-03T01:27:50ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/76595097659509Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver DiseaseCaihua Wang0Chunpeng Zhu1Liming Shao2Jun Ye3Yimin Shen4Yuezhong Ren5Department of Gastroenterology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaDepartment of Gastroenterology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaDepartment of Gastroenterology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaDepartment of Gastroenterology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaDepartment of Endocrinology and Metabolism, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, ChinaNonalcoholic fatty liver disease (NAFLD) is a major health threat around the world and is characterized by dysbiosis. Primary bile acids are synthesized in the liver and converted into secondary bile acids by gut microbiota. Recent studies support the role of bile acids in modulating dysbiosis and NAFLD, while the mechanisms are not well elucidated. Dysbiosis may alter the size and the composition of the bile acid pool, resulting in reduced signaling of bile acid receptors such as farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5). These receptors are essential in lipid and glucose metabolism, and impaired bile acid signaling may cause NAFLD. Bile acids also reciprocally regulate the gut microbiota directly via antibacterial activity and indirectly via FXR. Therefore, bile acid signaling is closely linked to dysbiosis and NAFLD. During the past decade, stimulation of bile acid receptors with their agonists has been extensively explored for the treatment of NAFLD in both animal models and clinical trials. Early evidence has suggested the potential of bile acid receptor agonists in NAFLD management, but their long-term safety and effectiveness need further clarification.http://dx.doi.org/10.1155/2019/7659509
spellingShingle Caihua Wang
Chunpeng Zhu
Liming Shao
Jun Ye
Yimin Shen
Yuezhong Ren
Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
Mediators of Inflammation
title Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
title_full Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
title_fullStr Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
title_full_unstemmed Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
title_short Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
title_sort role of bile acids in dysbiosis and treatment of nonalcoholic fatty liver disease
url http://dx.doi.org/10.1155/2019/7659509
work_keys_str_mv AT caihuawang roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease
AT chunpengzhu roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease
AT limingshao roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease
AT junye roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease
AT yiminshen roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease
AT yuezhongren roleofbileacidsindysbiosisandtreatmentofnonalcoholicfattyliverdisease